A trial is set to begin on Wednesday in Chicago in a case brought by four families who allege that baby ​formula made by Abbott Laboratories caused their premature infants to develop a dangerous bowel ...
A Chicago trial begins Wednesday. Four families claim Abbott Laboratories' baby formula caused a dangerous bowel disease in their premature infants. The lawsuits accuse Abbott of failing to warn about ...
Novo Nordisk and Eli Lilly have generated billions of dollars in revenue selling weight loss drugs. Abbott Labs is launching a complementary product for those on the weight loss path. Abbott Labs is ...
Abbott Lab's stock bucks a broad market selloff, after quarterly profit extends a long streak of beats on the back of strong demand for diabetes products Abbott Laboratories saw a big jump in demand ...
A major wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' (NYSE:ABT) FreeStyle Libre 3 and Libre 3 Plus glucose monitoring systems. The claim links the products to seven ...
A product made in Columbus reached a major milestone at the end of 2024. Ensure, a nutritional drink made by Abbott Laboratories in Columbus, surpassed $3 billion is annual global sales, according to ...
StockStory.org on MSN
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 ...
Abbott Laboratories reported strong Q4 2023 earnings, with year-over-year growth in EPS and revenue. The company's 2024 guidance projects further growth and improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results